title: Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset.
authors.forename: Ester
authors.initials: E
authors.lastname: Orlandi
authors.forename: Paolo
authors.initials: P
authors.lastname: Bernasconi
authors.forename: Marina
authors.initials: M
authors.lastname: Boni
authors.forename: Silvia
authors.initials: S
authors.lastname: Calatroni
authors.forename: Mario
authors.initials: M
authors.lastname: Lazzarino
mesh_terms: D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D020732:Cytogenetic Analysis; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D010885:Pipobroman / Q000627:therapeutic use*; D012333:RNA, Messenger / Q000032:analysis; D012008:Recurrence; D012074:Remission Induction / Q000379:methods; D013920:Thrombocythemia, Essential / Q000209:etiology*; D013997:Time Factors
chemical_list: D018906:Antineoplastic Agents, Alkylating; D012333:RNA, Messenger; D010885:Pipobroman; D016044:Fusion Proteins, bcr-abl